Litcius/Paper detail

New Horizons in Microbiota and Metabolic Health Research

Sidharth P. Mishra, Shalini Jain, Subhash Taraphder, Hariom Yadav

2020The Journal of Clinical Endocrinology & Metabolism17 citationsDOIOpen Access PDF

Abstract

Decade-old studies have demonstrated that microbes living in our gut (microbiota) contribute to both maintaining normal metabolic function and to the pathology of metabolic diseases, such as obesity and diabetes. Emerging evidence suggests that gut microbiota influences the personalized effects of diets and drugs and impact the gut-brain axis and leaky gut inflammation to control metabolic function/diseases. Gut microbiota can be an ideal source of prognostic markers and therapies for metabolic diseases. Here we discuss the emerging concepts in the area of microbiota and metabolic interactions in personalized nutrition, drug response, and disease prognosis.

Topics & Concepts

Gut floraDiseaseMetabolic diseaseInflammationBiologyGut–brain axisFunction (biology)ObesityDiabetes mellitusMetabolic syndromeBioinformaticsNew horizonsMedicineImmunologyInternal medicineEndocrinologyGeneticsEngineeringSpacecraftAerospace engineeringGut microbiota and healthDiet and metabolism studiesNutrition, Genetics, and Disease
New Horizons in Microbiota and Metabolic Health Research | Litcius